The SURMOUNT-1 data showed 75% fat loss and 25% lean mass loss with tirzepatide alone
Below, well break down how cagrilintide works, what clinical trials show so far, how it compares with existing options like Wegovy and Zepbound, and what the road ahead may look like for approval and availability
But until human studies are done, it remains on the frontier of regenerative medicine
Food and Drug Administration (FDA), and are not intended to diagnose, treat, cure, or prevent any disease or medical condition
Does the injection hurt
The peptide, derived from the C-terminal fragment of human growth hormone (amino acids 176-191), targets adipose tissue specifically without the broader metabolic effects associated with full growth hormone therapy